| __timestamp | Celldex Therapeutics, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 111110000 |
| Thursday, January 1, 2015 | 100171000 | 129714000 |
| Friday, January 1, 2016 | 102726000 | 139574000 |
| Sunday, January 1, 2017 | 96171000 | 218502000 |
| Monday, January 1, 2018 | 66449000 | 322876000 |
| Tuesday, January 1, 2019 | 42672000 | 427320000 |
| Wednesday, January 1, 2020 | 42534000 | 523667000 |
| Friday, January 1, 2021 | 53311000 | 491707000 |
| Saturday, January 1, 2022 | 82258000 | 515083000 |
| Sunday, January 1, 2023 | 118011000 | 241294000 |
Data in motion
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Galapagos NV and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Galapagos NV consistently outpaced Celldex in R&D expenditure, peaking in 2020 with a staggering 370% increase from 2014 levels. In contrast, Celldex's R&D spending fluctuated, with a notable dip in 2019, before rebounding by 177% in 2023 compared to 2020. This divergence highlights Galapagos NV's aggressive investment strategy, potentially positioning it for greater innovation and market leadership. Meanwhile, Celldex's more variable spending may reflect a strategic pivot or resource reallocation. As the biotech industry evolves, these investment patterns could significantly impact each company's future trajectory and competitive edge.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Galapagos NV
R&D Spending Showdown: BeiGene, Ltd. vs Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Celldex Therapeutics, Inc. Allocate Funds
Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.